
    
      This study will enroll male and female patients with migraine headache with or without aura.
      The study will randomize ~160 patients, 1:1:1:1 to receive one of the following treatments:
      1.25 mg Staccato Loxapine; 2.5 mg Staccato Loxapine; 5 mg Staccato Loxapine; Staccato
      Placebo.
    
  